Company research / SYBX

SYNLOGIC, INC. (SYBX)

CIK 0001527599 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, SYNLOGIC, INC. reported revenue of $0. Revenue fell 100.0% from the prior annual period.

Key ratios (year ended 2025-12-31)

-8.5%
Return on year-end equity
-100.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-08-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.